SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following reports that John Ternus is a leading candidate to succeed Tim Cook, sparking community debate about the company's future direction. This news emerges as the stock experiences a notable downturn, prompting many to call it an oversold 'buy the dip' opportunity while others express skepticism over Apple's competitive position in AI, especially after Google recently surpassed its market capitalization.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following positive FDA feedback indicating its existing data is sufficient for a Biologics License Application for sonelokimab in hidradenitis suppurativa, significantly de-risking its path to market. This clarity has ignited strong community discussion, highlighting the stock as undervalued and a prime buyout candidate, with many speculating on Merck's renewed interest and the potential for a substantial short squeeze.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending due to sharp stock price volatility following preliminary Q4 results and future revenue guidance that projected a decline in DefenCath sales. While many investors express frustration and accuse management of mishandling expectations, a significant portion of the community sees the downturn as an overreaction, emphasizing the strong Q4 financial performance, the diversified pipeline from the Melinta acquisition, and compelling positive real-world data for DefenCath.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is a focal point for investors following a strong earnings report that exceeded revenue and profitability expectations, driven by rapid expansion into high-performance computing. The community is actively discussing the company's robust pipeline, including advanced negotiations for significant new data center capacity, which could substantially increase its contracted revenue and potentially pressure short positions. This momentum positions the company as a key infrastructure provider in the booming AI sector.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending amid a significant surge in trading volume and price action, with community members enthusiastically discussing a potential breakout and a "next leg up." Bullish sentiment is fueled by anticipation of key 2026 developments in decentralized AI, DePIN, and secure data monetization, alongside its strong regulatory standing in Japan. Conversely, some participants remain wary, labeling the current rally as a "pump and dump" and questioning its sustainability given past volatility.

flyExclusive, Inc. engages in owning and operating jet aircraft for private jet passengers. It manages all aspects of the customer experience, in-house maintenance, repair, and overhaul services, including paint, interiors, and avionics capabilities. The company was founded by Thomas James Segrave, Jr. in 2015 and is headquartered in Kinston, NC.

flyExclusive Inc. - Ordinary Shares - Class A

flyExclusive Inc. is trending sharply after announcing a partnership to become an authorized Starlink Aviation dealer, integrating SpaceX's high-speed internet into its private jet fleet and MRO services. This news has ignited significant community excitement, with many speculating on substantial price appreciation due to the low float and its connection to the Starlink ecosystem. The stock is seeing extreme volatility and multiple trading halts as investors weigh the long-term impact of this strategic move against its rapid ascent.

iPower, Inc. engages in the online retail and supply of consumer home, garden, in-home farming, pet, and wellbeing products. It sells its brands such as Simple Deluxe, YSSOA, Zenhydro, Flourish, iPOWER, iFarm, FluffyDream, ScratchMe, and HealSmart through zenhydro.com, simpledeluxe.com, and various third-party online platforms. The company offers grow light systems, advanced heating, ventilation and air conditioning (HVAC) systems, water pumps, heaters, chillers and filters, nutrient and fertilizer delivery systems, and various growing media typically made from soil, rock wool or coconut fiber. It also provides home goods supplies including commercial fans, floor and wall fans, storage and shelving units, and chairs. The company was founded by Chenlong Tan and Allan Huang on April 11, 2018 and is headquartered in Rancho Cucamonga, CA.

iPower Inc

iPower Inc. is currently trending with high community interest, largely fueled by its extremely low public float after a recent capital structure change, leading to active speculation about a potential short squeeze. Investors are also discussing the company's strategic foray into digital assets, including initial purchases of Bitcoin and Ethereum, which is generating varied perspectives. This combination of tight market supply and a new crypto treasury strategy makes it a highly debated stock.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion Inc. is trending after providing an update on its accelerating AI back pain platform, Nociscan, reporting substantial scan volume growth and a robust, debt-free balance sheet with an extended cash runway. The community is buzzing about the stock's extremely low float and significant cash per share, fueling speculation for a potential short squeeze and considerable upward price movement. Traders are actively accumulating shares, anticipating a notable revaluation, despite some ongoing calls of manipulation.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending due to its strategic pivot towards hybrids and traditional powertrains, alongside a substantial restructuring charge related to scaling back certain EV initiatives. This shift follows robust 2025 sales, particularly in trucks and SUVs, and has sparked community discussions regarding Ford's long-term profitability, market position, and recent analyst upgrades. The company's adaptability to evolving consumer demand and regulatory landscapes is a key talking point among investors.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Morgan Stanley resumed coverage of Aviva after the Direct Line deal

FTSE 100 today: Index opens higher, pound gains, U.K. house prices drop in June

   Sainsbury   ’s (LON:SBRY) reports 4.9% sales rise in first quarter

FTSE 100 today: index open lower; U.K. Q1 growth tops forecasts; earnings in focus

Investing.com -- British stocks opened lower on Thursday, extending the previous day’s losses, even as data showed the U.K. economy grew more than expected in Q1, with   National Grid   ,   3i   (LON:III), and   Aviva   among the major companies reporting today.

Aviva tops profit expectations for 2024 on strong premiums, shares slightly up

Investing.com --  Aviva  (LON:AV) exceeded profit expectations for 2024, driven by strong double-digit growth in its general insurance premiums. The British insurer also confirmed that its planned £3.7 billion acquisition of  Direct Line  (LON:DLGD) is progressing as expected.

Barclays upgrades Aviva to 'overweight,' citing growth from Direct Line deal

Aviva upgraded to 'overweight' by J.P. Morgan amid growth plans

Aviva Plc is a holding company, which engages in the provision of long-term insurance and savings, general and health insurance, and fund management products and services. It operates through the following segments: United Kingdom and Ireland; Canada; France; Italy; Poland; and Other. The United Kingdom and Ireland segment offers risks associated with motor vehicles, property and liability, and medical expenses insurance cover to individuals and businesses. The Canada segment refers to the personal and commercial lines insurance products distributed through insurance brokers. The France segment consists of long-term and general insurance businesses. The Italy segment provides savings, investments, pension, and protection products to the life and non-domestic insurance markets. The Poland segment comprises of long-term business and general insurance business in Lithuania. The Other segment includes the long-term business operations in China, India, and Singapore; and life operations in Turkey. The company was founded on November 12, 1696 and was headquartered in London, the United Kingdom.

Aviva Plc - ADR

SpaceX

Discord

OpenAI

Other - Comment Below

A few major private companies are being discussed as potential IPO candidates in 2026 — including SpaceX, Discord, Databricks, OpenAI, Anthropic, and Deel. IPO timelines can shift, but if one of these listings happens this year, which are you most excited to watch?

Which Potential 2026 IPO Are You Most Excited For?

AV
Aviva plc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AV News

AVAviva plc